alm2, appreciate your comments. The upside is still there for Amarin. I’m looking forward to watching the new CEO in action. Something is going to happen:
- buy out soon
- buy out later (after Amarin puts some performance on the table)
- future catalysts come to fruition
- Amarin truly goes it alone and becomes the asset it should have been or close to it
Time will tell. I like others would like to see a better return on our investment sooner rather than later. Five more years to wait until it hits $22 is a bit much, especially if you have been here since 2010. Nevertheless, I am on the same page with your optimism. If this investment has taught us anything it might be the need to be resilient and patient. The drug is too good to let it slip away. They know it. Just need a great leader within the company to establish the vision, sell that vision and execute said vision.
News 
Market Data 
Discover 
